Total Payments
$3,337
2024 Payments
$801.67
Companies
24
Transactions
143
Medicare Patients
3,021
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$3,322 (99.6%)
Education$14.87 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,322 | 142 | 99.6% |
| Education | $14.87 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $444.35 | 16 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $338.80 | 7 | $0 (2024) |
| Amgen Inc. | $320.88 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $270.83 | 2 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $261.25 | 14 | $0 (2024) |
| Vifor Pharma, Inc. | $204.27 | 15 | $0 (2023) |
| Relypsa, Inc. | $198.67 | 12 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $139.32 | 7 | $0 (2024) |
| Exact Sciences Corporation | $125.00 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $125.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $801.67 | 29 | Bayer Healthcare Pharmaceuticals Inc. ($159.43) |
| 2023 | $540.24 | 24 | AstraZeneca Pharmaceuticals LP ($199.46) |
| 2022 | $482.33 | 19 | AstraZeneca Pharmaceuticals LP ($146.79) |
| 2021 | $429.82 | 30 | Vifor Pharma, Inc. ($117.36) |
| 2020 | $181.63 | 11 | Amgen Inc. ($61.59) |
| 2019 | $230.81 | 8 | Gilead Sciences, Inc. ($125.00) |
| 2018 | $99.05 | 7 | Relypsa, Inc. ($58.32) |
| 2017 | $571.10 | 15 | SANOFI-AVENTIS U.S. LLC ($270.83) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.43 | General |
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: LIVER DISEASE | ||||||
| 11/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Cardio-renal | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.22 | General |
| 09/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.20 | General |
| 08/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $14.93 | General |
| 08/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.53 | General |
| 07/15/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: NEPHROLOGY | ||||||
| 06/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/01/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $10.50 | General |
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: Cardio-renal | ||||||
| 05/03/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Inflammation | ||||||
| 04/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.30 | General |
| 03/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Inflammation | ||||||
| 03/22/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: NEPHROLOGY | ||||||
| 03/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Cardio-renal | ||||||
| 02/09/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 705 | 2,960 | $602,721 | $403,820 |
| 2022 | 10 | 641 | 2,414 | $364,242 | $255,505 |
| 2021 | 10 | 796 | 2,902 | $473,370 | $320,904 |
| 2020 | 10 | 879 | 3,475 | $583,400 | $362,967 |
Total Patients
3,021
Total Services
11,751
Medicare Billing
$1.3M
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 127 | 770 | $345,258 | $232,415 | 67.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 145 | 1,274 | $121,744 | $84,133 | 69.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 74 | 133 | $49,656 | $33,174 | 66.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 39 | 239 | $20,793 | $14,548 | 70.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 141 | 201 | $21,462 | $14,265 | 66.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Office | 2023 | 18 | 101 | $9,180 | $6,148 | 67.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 101 | $11,524 | $5,600 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 58 | $9,389 | $4,371 | 46.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 34 | $4,880 | $3,357 | 68.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 25 | $4,152 | $2,781 | 67.0% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 11 | 11 | $2,830 | $1,918 | 67.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $1,852 | $1,112 | 60.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 143 | 1,218 | $109,567 | $74,494 | 68.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 55 | 220 | $87,100 | $68,082 | 78.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Facility | 2022 | 37 | 113 | $45,200 | $35,590 | 78.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 45 | 299 | $28,715 | $18,642 | 64.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 135 | 182 | $29,486 | $15,601 | 52.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 36 | 60 | $20,003 | $15,463 | 77.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Facility | 2022 | 16 | 27 | $9,450 | $7,067 | 74.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 127 | $11,954 | $6,661 | 55.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 71 | $7,829 | $6,225 | 79.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 62 | $9,166 | $3,887 | 42.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 19 | $3,534 | $2,214 | 62.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $2,238 | $1,580 | 70.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Facility | 2021 | 59 | 413 | $165,200 | $130,748 | 79.1% |
About Dr. Sam Rae, MD
Dr. Sam Rae, MD is a Nephrology healthcare provider based in Wayne, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649277294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Rae, MD has received a total of $3,337 in payments from pharmaceutical and medical device companies, with $801.67 received in 2024. These payments were reported across 143 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,322).
As a Medicare-enrolled provider, Rae has provided services to 3,021 Medicare beneficiaries, totaling 11,751 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Wayne, NJ
- Active Since 06/28/2005
- Last Updated 08/05/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1649277294
Products in Payments
- Veltassa (Drug) $402.94
- Kerendia (Drug) $338.80
- JYNARQUE (Drug) $277.28
- FARXIGA (Drug) $231.40
- Parsabiv (Drug) $172.33
- SOLIQUA (Drug) $145.83
- BREZTRI (Drug) $125.00
- Cologuard Collection Kit (Device) $125.00
- Epclusa (Drug) $125.00
- TOUJEO (Drug) $125.00
- REZDIFFRA (Drug) $124.99
- Velphoro (Drug) $107.14
- ZEPATIER (Drug) $90.00
- LOKELMA (Drug) $87.95
- AURYXIA (Drug) $86.71
- BENLYSTA (Biological) $76.63
- ACTHAR (Biological) $71.42
- INJECTAFER (Drug) $69.57
- IBSRELA (Drug) $65.27
- TAVNEOS (Drug) $45.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Wayne
Dr. Sanjay Shah, Md. Mbbs, MD. MBBS
Nephrology — Payments: $7,200
Nephrology $7,200
Dr. Shazia Raza, Md, MD
Nephrology — Payments: $3,790
Nephrology $3,790
Dr. Ignazio Fazio, Md, MD
Nephrology — Payments: $2,041
Nephrology $2,041
Anuradha Konkesa, Md, MD
Nephrology — Payments: $1,709
Nephrology $1,709
Dr. Kevin Vitting, Md, MD
Nephrology — Payments: $1,612
Nephrology $1,612
Dr. Pat Audia, Md, MD
Nephrology — Payments: $1,448
Nephrology $1,448